Cite
Mukherjee S, Chakraborty M, Ulmasov B, et al. Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis. Mol Metab. 2021;54:101364doi: 10.1016/j.molmet.2021.101364.
Mukherjee, S., Chakraborty, M., Ulmasov, B., McCommis, K., Zhang, J., Carpenter, D., Msengi, E. N., Haubner, J., Guo, C., Pike, D. P., Ghoshal, S., Ford, D. A., Neuschwander-Tetri, B. A., & Chakraborty, A. (2021). Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis. Molecular metabolism, 54101364. https://doi.org/10.1016/j.molmet.2021.101364
Mukherjee, Sandip, et al. "Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis." Molecular metabolism vol. 54 (2021): 101364. doi: https://doi.org/10.1016/j.molmet.2021.101364
Mukherjee S, Chakraborty M, Ulmasov B, McCommis K, Zhang J, Carpenter D, Msengi EN, Haubner J, Guo C, Pike DP, Ghoshal S, Ford DA, Neuschwander-Tetri BA, Chakraborty A. Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis. Mol Metab. 2021 Oct 28;54:101364. doi: 10.1016/j.molmet.2021.101364. Epub 2021 Oct 28. PMID: 34757046; PMCID: PMC8609165.
Copy
Download .nbib